TY - JOUR
T1 - Significance of an abnormal ankle-brachial index in patients with established coronary artery disease with and without associated diabetes mellitus
AU - Banerjee, Subhash
AU - Vinas, Ariel
AU - Mohammad, Atif
AU - Hadidi, Omar
AU - Thomas, Rahul
AU - Sarode, Karan
AU - Banerjee, Avantika
AU - Garg, Puja
AU - Weideman, Rick A.
AU - Little, Bertis B.
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
This project was supported by an institutional XLPAD Study grant from Boston Scientific, Natick, Massachusetts.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2014/4/15
Y1 - 2014/4/15
N2 - An abnormal ankle-brachial index (ABI) is associated with higher risk for future cardiovascular (CV) events; however, it is unknown whether this association is true in patients with established coronary artery disease (CAD) and associated diabetes mellitus (DM). We evaluated 679 patients with stable CAD enrolled in the Excellence in Peripheral Arterial Disease and Veterans Affairs North Texas Healthcare System peripheral arterial disease databases. ABI and 12-month major adverse CV events (MACEs, a composite of all-cause death, nonfatal myocardial infarction, need for repeat coronary revascularization, and ischemic stroke) were assessed. Cox proportional hazard models were used to assess the association of ABI and DM with subsequent CV events. An abnormal ABI (<0.9 or >1.4) was present in 72% of patients with stable CAD and 68% had DM. Using patients without DM and normal ABI as reference, the adjusted hazard ratio for 12-month MACE was 1.7 (95% confidence interval [CI] 0.71 to 4.06) for patients with DM and normal ABI; 2.03 (95% CI 0.83 to 4.9) for patients without DM with abnormal ABI; and 4.85 (95% CI 2.22 to 10.61) for patients with DM and abnormal ABI. In conclusion, in patients with stable CAD, an abnormal ABI confers an incremental risk of MACE in addition to DM and traditional CV risk factors.
AB - An abnormal ankle-brachial index (ABI) is associated with higher risk for future cardiovascular (CV) events; however, it is unknown whether this association is true in patients with established coronary artery disease (CAD) and associated diabetes mellitus (DM). We evaluated 679 patients with stable CAD enrolled in the Excellence in Peripheral Arterial Disease and Veterans Affairs North Texas Healthcare System peripheral arterial disease databases. ABI and 12-month major adverse CV events (MACEs, a composite of all-cause death, nonfatal myocardial infarction, need for repeat coronary revascularization, and ischemic stroke) were assessed. Cox proportional hazard models were used to assess the association of ABI and DM with subsequent CV events. An abnormal ABI (<0.9 or >1.4) was present in 72% of patients with stable CAD and 68% had DM. Using patients without DM and normal ABI as reference, the adjusted hazard ratio for 12-month MACE was 1.7 (95% confidence interval [CI] 0.71 to 4.06) for patients with DM and normal ABI; 2.03 (95% CI 0.83 to 4.9) for patients without DM with abnormal ABI; and 4.85 (95% CI 2.22 to 10.61) for patients with DM and abnormal ABI. In conclusion, in patients with stable CAD, an abnormal ABI confers an incremental risk of MACE in addition to DM and traditional CV risk factors.
UR - http://www.scopus.com/inward/record.url?scp=84897454203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897454203&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2014.01.403
DO - 10.1016/j.amjcard.2014.01.403
M3 - Article
C2 - 24602299
AN - SCOPUS:84897454203
SN - 0002-9149
VL - 113
SP - 1280
EP - 1284
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 8
ER -